ArticleFrontiers in neurology2025
Parkinson's disease detection using spectrogram-based multi-model feature fusion networks.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Demographic Confounding in Voice-Based Parkinson Disease Screening: Methodological Analysis of the Bridge2AI Voice Dataset.Journal of medical Internet research · 2026Article
- A Machine Learning Approach to Voice-Based Parkinson Disease Screening Using Multiview Spectrogram and Speech Recognition Features: Diagnostic Study.JMIR medical informatics · 2026Article
- The future digital outpatient clinic for movement disorders: from technological innovation to ethical and systemic implementation-a position paper.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- A novel class-attention transformer-driven feature fusion technique-based speech disorder classification.Frontiers in medicine · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Parkinson's disease (PD) is a common neurodegenerative disorder. Traditional diagnostic methods, relying on clinical assessment and imaging, are often invasive, costly, and require specialized personnel, posing barriers to early detection. As approximately 90% of PD patients develop vocal impairments, vocal analysis emerges as a promising non-invasive diagnostic tool. However, individual deep learning models are often limited by overfitting and poor generalizability. Methods: This study proposes a PD classification method using spectrogram feature fusion with pre-trained convolutional neural networks (CNNs). Voice recordings were obtained from 61 PD patients and 70 healthy controls (HC) at the First Affiliated Hospital of Henan University of Science and Technology. Preprocessing the raw speech signals yielded 2,476 spectrograms. Three pre-trained models, DenseNet121, MobileNetV3-Large, and ShuffleNetV2, were used for feature extraction. The output of MobileNetV3-Large was adjusted using a 1 × 1 convolutional layer to ensure dimensional alignment before features were fused via summation. Results: Evaluation using 5-fold cross-validation demonstrated that models employing feature fusion consistently outperformed individual models across all metrics. Specifically, the fusion of MobileNetV3-Large and ShuffleNetV2 achieved the highest accuracy of 95.56% and an AUC of 0.99. Comparative experiments with existing state-of-the-art methods confirmed the competitive performance of the proposed approach. Discussion: The fusion of multi-model features more effectively captures subtle pathological signatures in PD speech, overcoming the limitations of single models. This method provides a reliable, low-cost, and non-invasive tool for auxiliary PD diagnosis, with significant potential for clinical application. The code is available at https://github.com/lvrongfu/pjs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.